A SARS DNA vaccine induces neutralizing antibody and cellular immune responses in healthy adults in a Phase I clinical trial

[1]  H. Deng,et al.  Neutralizing Antibodies in Patients with Severe Acute Respiratory Syndrome-Associated Coronavirus Infection , 2004, The Journal of Infectious Diseases.

[2]  J. Mascola,et al.  A Human T-Cell Leukemia Virus Type 1 Regulatory Element Enhances the Immunogenicity of Human Immunodeficiency Virus Type 1 DNA Vaccines in Mice and Nonhuman Primates , 2005, Journal of Virology.

[3]  J. Kwang,et al.  Immunological Characterization of the Spike Protein of the Severe Acute Respiratory Syndrome Coronavirus , 2004, Journal of Clinical Microbiology.

[4]  X. L. Liu,et al.  Isolation and Characterization of Viruses Related to the SARS Coronavirus from Animals in Southern China , 2003, Science.

[5]  T. Gallagher,et al.  Murine Coronavirus Spike Glycoprotein , 2001 .

[6]  R. Koup,et al.  Human memory T cell responses to SARS-CoV E protein , 2006, Microbes and Infection.

[7]  R. Koup,et al.  Long-lived effector/central memory T-cell responses to severe acute respiratory syndrome coronavirus (SARS-CoV) S antigen in recovered SARS patients , 2006, Clinical Immunology.

[8]  Obi L. Griffith,et al.  The Genome Sequence of the SARS-Associated Coronavirus , 2003, Science.

[9]  G. Nabel,et al.  Generation of Synthetic Severe Acute Respiratory Syndrome Coronavirus Pseudoparticles: Implications for Assembly and Vaccine Production , 2004, Journal of Virology.

[10]  R. Koup,et al.  A DNA Vaccine for Ebola Virus Is Safe and Immunogenic in a Phase I Clinical Trial , 2006, Clinical and Vaccine Immunology.

[11]  Yan Liu,et al.  Safety and Immunogenicity from a Phase I Trial of Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine , 2007, Antiviral therapy.

[12]  Michelle M. Packard,et al.  Prior Infection and Passive Transfer of Neutralizing Antibody Prevent Replication of Severe Acute Respiratory Syndrome Coronavirus in the Respiratory Tract of Mice , 2004, Journal of Virology.

[13]  Wenhui Li,et al.  A 193-Amino Acid Fragment of the SARS Coronavirus S Protein Efficiently Binds Angiotensin-converting Enzyme 2* , 2004, Journal of Biological Chemistry.

[14]  Gary J. Nabel,et al.  A DNA vaccine induces SARS coronavirus neutralization and protective immunity in mice , 2004, Nature.

[15]  B. Murphy,et al.  Contributions of the structural proteins of severe acute respiratory syndrome coronavirus to protective immunity. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[16]  J. Mascola,et al.  Efficient protein boosting after plasmid DNA or recombinant adenovirus immunization with HIV-1 vaccine constructs. , 2007, Vaccine.

[17]  K. Holmes,et al.  SARS-associated coronavirus. , 2003, The New England journal of medicine.

[18]  T. Gallagher.  Murine coronavirus spike glycoprotein. Receptor binding and membrane fusion activities. , 2001, Advances in experimental medicine and biology.

[19]  A. Danchin,et al.  The Severe Acute Respiratory Syndrome , 2003 .

[20]  M. Fay,et al.  A West Nile virus DNA vaccine induces neutralizing antibody in healthy adults during a phase 1 clinical trial. , 2007, The Journal of infectious diseases.

[21]  J. Mascola,et al.  Phase I clinical evaluation of a six-plasmid multiclade HIV-1 DNA candidate vaccine. , 2007, Vaccine.

[22]  R. Koup,et al.  Long-lived memory T lymphocyte responses against SARS coronavirus nucleocapsid protein in SARS-recovered patients , 2006, Virology.

[23]  R. Koup,et al.  Persistent memory CD4+ and CD8+ T-cell responses in recovered severe acute respiratory syndrome (SARS) patients to SARS coronavirus M antigen. , 2007, The Journal of general virology.

[24]  K. Subbarao,et al.  The Immunobiology of SARS*. , 2007, Annual review of immunology.

[25]  K. Subbarao,et al.  pH-Dependent Entry of Severe Acute Respiratory Syndrome Coronavirus Is Mediated by the Spike Glycoprotein and Enhanced by Dendritic Cell Transfer through DC-SIGN , 2004, Journal of Virology.

[26]  J. Mascola,et al.  Phase 1 safety and immunogenicity evaluation of a multiclade HIV-1 DNA candidate vaccine. , 2006, The Journal of infectious diseases.

[27]  Christian Drosten,et al.  Characterization of a Novel Coronavirus Associated with Severe Acute Respiratory Syndrome , 2003, Science.